The Peter Attia Drive cover image

#19 - Dave Feldman: stress testing the lipid energy model

The Peter Attia Drive

CHAPTER

Does Inhibiting PCS K9 Make a Difference?

Fourier and odyssey were trials that looked at two pc s k nine inhibitors. Fourier took patients with an average l d l calestral of something like 90 or 92 milligrams per decileter. These patients were already on the maximum tolerated dose of a staton, ok? And in two point two years, showed a reduction in events. The null hypothesis should be, it should have never worked. You should have needed 20 years to show any benefit when you understand allan snyderman's lifetime exposure model.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner